Home › Meningioma › Pennsylvania
Meningioma clinical trials in Pennsylvania
4 studies for Meningioma are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
- Thomas Jefferson University Hospital, Philadelphia
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT06955169Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Lehigh Valley Hospital - Muhlenberg, Bethlehem
- Pocono Medical Center, East Stroudsburg
- and 4 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT02523014Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- St Luke's University Health, Sacred Heart Campus, Allentown
- Penn State Health, Hershey
- Allegheny Health Network, Pittsburgh
RecruitingObservational study
All ages · All sexes · Updated Jul 22, 2026 · NCT04427384Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
- Children's Hospital of Philadelphia, Philadelphia
RecruitingPhase 1/2
Ages 4 to 39 · All sexes · Updated Jul 20, 2026 · NCT05278208From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.